PANOVA-3: Pivotal randomized open-label study of Tumor Treating Fields (TTFields 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
Brief description of study
To test the efficacy and safety of gemcitabine and nab-paclitaxel, with or without TTFields, using the NovoTTF-100L(P) System as a front-line therapy for locally-advanced pancreatic adenocarcinoma patients
Clinical Study Identifier: s17-01038
ClinicalTrials.gov Identifier: NCT03377491
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
